France 24: Why an Israeli company is developing an oral Covid vaccine

Oramed CEO Nadav Kidron spoke to AFP about the advantages of Oravax Medical’s oral Covid-19 vaccine: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes. Oral vaccines are particularly attractive for the developing world, because they reduce the logistical burden of immunization campaigns. Read more here.

Forbes: Oral Covid Vaccine Set To Begin Trials In Israel

Forbes discusses how Israel is gearing up to host the first clinical trials of Oravax’s oral Covid-19 vaccine, which could help boost access to vaccines around the world. The vaccine should be “much more resistant to Covid-19 variants,” Kidron said, as it trains the immune system against three viral proteins. Read more here.

Join our mailing list

Skip to content